| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $1.77 ▲ +1.77% | Yesterday | $1.72 ▼ -0.74% | Tomorrow's ProQR Therapeutics N.V. Ordinary Shares (PRQR) setup is anchored to $1.74 and targets $1.77 (+1.77%). The near-term read is upside; watch $1.79 / $1.68 because daily realized volatility is about 8.00%. |
Tomorrow's ProQR Therapeutics N.V. Ordinary Shares (PRQR) setup is anchored to $1.74 and targets $1.77 (+1.77%). The near-term read is upside; watch $1.79 / $1.68 because daily realized volatility is about 8.00%. | ||||
| Week | $1.83 ▲ +5.50% | Last Week | $1.69 ▼ -2.31% | The 7-day ProQR Therapeutics N.V. Ordinary Shares model moves from $1.69 to $1.83 (+5.50%). It gives upside momentum context for this stock, so breaks around $1.79 / $1.68 matter more than a single tick. |
The 7-day ProQR Therapeutics N.V. Ordinary Shares model moves from $1.69 to $1.83 (+5.50%). It gives upside momentum context for this stock, so breaks around $1.79 / $1.68 matter more than a single tick. | ||||
| Month | $1.94 ▲ +11.71% | Last Month | $1.65 ▼ -4.92% | The 1-month ProQR Therapeutics N.V. Ordinary Shares target is $1.94 (+11.71%), compared with the live reference near $1.74. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month ProQR Therapeutics N.V. Ordinary Shares target is $1.94 (+11.71%), compared with the live reference near $1.74. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $2.10 ▲ +21.03% | Last Year | $1.58 ▼ -8.83% | The 1-year ProQR Therapeutics N.V. Ordinary Shares scenario points to $2.10 (+21.03%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year ProQR Therapeutics N.V. Ordinary Shares scenario points to $2.10 (+21.03%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $2.48 ▲ +42.86% | 5 Years Ago | $1.42 ▼ -18.00% | The 5-year ProQR Therapeutics N.V. Ordinary Shares view is $2.48 (+42.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year ProQR Therapeutics N.V. Ordinary Shares view is $2.48 (+42.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $1.74 | Mid |
| Daily Change | -5.71% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 70% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $1.74 | Daily Change | -5.71% |
| Market Cap | $182.80M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.